...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: what comes next for Zen?
3
Jan 02, 2020 07:39PM

i like your thinking NextBlockBuster!!

 

glta

Share
New Message
Please login to post a reply